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ABSTRACT 
Objectives: This study was conducted to determine the feasibility of a 
group visit program for diabetes education and management led by a 
primary care provider in a primary care clinic setting. 
Intervention Design: A review of the literature about group visits for 
many diseases including diabetes is reported. Using this information, we 
designed a diabetes education program using a group visit model. The 
curriculum was based on the National Standards for Diabetes Self-
management Education and used the theory of stages of change and 
principles of active, adult learning. 
Methods: 32 subjects with Type II diabetes were recruited to enroll in the 
program over the course of eight months. Outcome measures included 
HgbA 1 c, body mass index, blood pressure, quality of life, and self-efficacy. 
Changes were measured at baseline, eight weeks, and six months. 
Results: Clinical outcomes demonstrated trends towards improvement 
with a 0.16% drop in HgbA 1 c at six months. Attitudes about diabetes and 
self-efficacy improved immediately after the sessions but returned to 
baseline at 6 months. Quality of life showed minimal improvement. 
Conclusions: A group visit program for diabetes education and 
management led by a primary care provider is feasible. Key 
implementation issues included limited patient recruitment and poor 
attendance rates. Future research is needed to study the development of 
a group model for continuing management of diabetes in primary care. 
INTRODUCTION 
Diabetes is a major contributor to morbidity and mortality in the 
United States and the world. An estimated 17 million people in the US 
have diabetes, with nearly 800,000 new cases each year, and diabetes is 
now the 61h leading cause of death in the US.[1] Direct and indirect costs 
were estimated at $98 billion in 1997.[1] Chronic complications of 
diabetes, including micro-vascular and macro-vascular disease, are 
known to be leading causes of blindness, renal failure, and non-traumatic 
amputation in the US. Major advances have been made in the 
management of diabetes with new oral medications, laser therapy to delay 
the progression of retinopathy, ace-inhibitors to delay renal disease, and 
more. Trials have successfully demonstrated the benefits of tight glycemic 
control in both Type I and Type II diabetes and the benefits of aggressive 
control of blood pressure in Type II patients.[2, 3] 
Despite these advances, our current healthcare system is not 
optimally treating patients with diabetes. An estimated 5.9 million people 
have diabetes but do not know it. [1] Many of these patients are not 
diagnosed until several years into the disease process, when 
complications have already begun. Equally discouraging is the number of 
patients who receive inadequate or ineffective treatment for their 
diabetes.[4] Data from the NHANES Ill Survey in 1988-1994 found that 
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18% of patients with diabetes had poor glycemic control with HbgA 1 c 
levels greater than 9.5%. [5] The Center for Disease Control and 
Prevention reports that, based on self-report, only 61% of diabetics have 
had annual dilated eye exams, 55% reported a foot exam in the last year, 
and only 18% reported a HgbA1c level measured in the last year.[6] 
The reasons for this inadequate management of diabetes involve 
many factors. One major issue is the nature of the disease. Like many 
chronic diseases, diabetes management involves lifestyle changes that 
are very difficult to make. Diabetes requires that the patient live with and 
manage the disease on a daily basis. Treatment entails self-monitoring of 
blood glucose, medication adherence, and appropriate medical follow-up 
for screening and prevention. Behaviors such as over-eating, poor food 
choices, smoking, and lack of exercise contribute to the development of 
the disease and its poor control. Recent evidence demonstrated that 
lifestyle change can be more powerful than medications for the prevention 
of Type II diabetes. However, to be successful, this intervention required 
an intensive, multidisciplinary team approach to motivate and maintain 
behavior change.[?] 
These challenging aspects of chronic management for diseases 
like diabetes bring into question our current health care system and its 
organization. The present structure evolved in an earlier era when acute 
illness predominated. One-on-one, brief and isolated office or hospital 
visits made sense. Today, financial pressures have made those visits 
3 
even briefer, often requiring physicians to see their patients for less than 
15 minutes. Clearly, this design does not meet the needs of patients with 
complex chronic diseases like diabetes. Physicians need time to 
introduce knowledge, teach skills, and motivate behavior change in 
addition to the medical management that must occur in those 15 minutes. 
To address these weaknesses, many have proposed creating new 
structures and systems for management of diabetes and other chronic 
diseases. Disease management programs, physician reminder systems, 
and use of multi-disciplinary teams have all been tried and, in some cases, 
found to be effective[8]. Others have implemented group visits for patients 
with diabetes; as education and self-management programs, support 
groups, and as ongoing management visits. Several successful programs 
have been implemented in large health care systems, but few programs 
have been studied on a smaller scale. Primary care physicians, often in 
smaller clinic settings, care for nearly 75% of patients with Type II 
diabetes.[9] The development of strategies that improve the quality and 
efficiency of care in primary care settings is essential. 
Therefore, we designed a diabetes education and management 
program using a group visit model, run by individual primary care 
providers in an academic family practice clinic. The unique feature of our 
program is the combination of the smaller clinic setting with a primary care 
provider-led group. The goal of this study is to assess the feasibility of this 
type of diabetes education and disease management program in a real-
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world clinical setting. This paper will review the literature on diabetes 
group visits and discuss the design and implementation of our program. 
Initial pilot study data will be presented from the first six cohorts. 
REVIEW OF LITERATURE ABOUT GROUP VISITS 
Many researchers and clinicians have proposed group visits for a 
wide variety of health-related concerns, including diabetes education and 
management. They argue that group visits offer an appealing efficiency for 
both providers and health care organizations. [1 0] The potential ability to 
provide higher quality care to more patients quickly has its obvious 
benefits. Physicians may prefer to offer the same counseling information 
once to many patients instead of giving a shortened version of that same 
education numerous times. Other practices have developed group visits 
to meet patient demands for increased access to their physicians and to 
health information.[11] 
Some researchers suggest that group visits can offer more than 
efficiency, noting that group communication and social support have the 
potential to motivate and reinforce behavior change. In a 1985 article, 
Tattersall, et al describe twelve potential "curative factors" of group 
psychotherapy for patients with diabetes.[12] These factors highlight the 
potential power of group interaction for education, social support, and 
motivation that cannot be reproduced by one-on-one interaction between 
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provider and patient (Table 1 ). Other literature suggests the importance of 
social support for health behavior change.[13] 
Many disease processes can benefit from using a group visit 
model. In practice, providers appear to develop group programs to meet 
three needs: 1) increased efficiency and productivity; 2) increased patient 
access to appointments; and 3) improved education and access to 
information. Stanford Health Partners led patient focus groups to identify 
ways that care could be improved and found that access to appointments 
and information were consistent needs for all patients.[11] Several small 
private practices have adopted provider-run groups for common conditions 
such as obesity, depression, and asthma.[14] Another application of the 
group model is for annual physicals-called Physicals Shared Medical 
Appointment.[15] These visits limit the traditional physical exam and, 
instead, focus on health maintenance, healthy lifestyle counseling, and 
prevention. Patients have the advantage of increased availability of 
physical appointment times, longer visits with the physician for counseling, 
and the opportunity to learn from peers. 
Group visits have also been studied for well childcare, emphasizing 
the education and guidance components of these preventive visits. 
Parents with children of similar ages can learn from each other and form a 
peer group for social support. One study demonstrated that well childcare 
could be equally effective when provided using group visits instead of 
individual visits.[16, 17] Furthermore, group visits were more efficient for 
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the providers, while allowing parents more time with the physician. 
Prenatal care can be provided with the same group framework, focusing 
on guidance, information sharing, and support.[18] 
Several large randomized controlled studies have been conducted 
using group visits for the care of the elderly or chronic disease. Wagner 
and Coleman studied the use of group visits for older patients with a 
chronic disease in a large HMO and found no change in outcomes or cost, 
but did find an improvement in satisfaction with care.[19] Another study by 
Beck et al looked at the use of groups for the elderly and found a 
decrease in emergency room and specialty visits, but an increase in 
primary care visits and phone calls. Both patients and physicians 
experienced improved satisfaction, and the overall cost of care for the 
group patients was less.[20] 
The concept of group visits for diabetes education and, more 
recently, for disease management is spreading. Group education 
programs have been done for years, though often without direct evidence 
of the effectiveness. Diabetic "mini-clinics" have been used in Britain for 
the past three decades as a way to provide specialized disease 
management in general practice.[21, 22] More recently in the United 
States, providers have developed comprehensive diabetes education and 
management using a group visit model. One family physician from Florida 
has developed a group visit model for several chronic diseases including 
diabetes, providing routine medical management, education, and support 
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at each visit.[23, 24] Another program in Sweden looked at pharmacy-run 
diabetes "circles" that provided education and social support.[25] A recent 
systematic review of 72 randomized controlled trials in diabetes self-
management training found great diversity among the types of programs 
offered.[26] Short-term measures such as knowledge, blood glucose 
testing skills, and self-reported dietary habits improved, but often without 
improved glycemic control. Important findings include the benefits of 
patient participation and collaboration, the value of reinforcing 
interventions, and the effectiveness of group interventions for lifestyle 
change. 
Several randomized controlled trials have examined the role of a 
group model. Detailed characteristics and findings for each trial are 
shown in Table 2. A 1988 study from Israel examined the role of small 
group education sessions as part of routine care compared to individual 
office visits alone. This early study did not demonstrate knowledge 
differences between the two groups, but did find reductions in fasting and 
post-prandial glucose (p=0.01) and in HgbA1 cat 12 months (p<=0.05).[27] 
Anderson studied a patient empowerment program. The goal of six 
weekly group sessions was "empowerment facilitating a path to personal 
self care." Patients who attended the sessions demonstrated increased 
self-efficacy scores (based on a diabetes attitude survey) and greater 
improvement in HgbA1c.[28] Ridgeway et al studied a practical education 
and behavior modification program implemented in a small private internal 
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medicine clinic. Patients attended monthly group sessions led by an RN 
or RD in addition to their routine office visits. Subjects in the intervention 
group had a 2.07% drop in HgbA1c at the end of 12 months compared to 
1.08% in the control group (p=0.0034).[29] A similar program in Denmark 
studied the effect of a group program for intensified lifestyle education and 
found limited change in diet and other targeted behaviors but did find 
reduction in overall HgbA1 c levels (p<0.0000001 ).[30] However, this was 
a multi-factorial intervention and much of the improvement in glycemic 
control is likely due to other aspects of the intervention such as medication 
adjustment and intensive target goals for the intervention group. 
On a larger scale, two randomized controlled trials have been I implemented in health maintenance organizations. Sadur et al studied the 
efficacy of a cluster visit for diabetes management. [31] Subjects received 
care provided by a large multi-disciplinary team with monthly group visits 
over a 6-month period. HgbA1c levels dropped by 1.3% in the 
intervention group compared to 0.2% in the control group (p<0.0001 ). 
Hospital and outpatient utilization were lower in the intervention group as 
well. Wagner et al studied the use of Chronic Care Clinics for diabetes in 
a large staff model HM0.[32] Subjects attended half-day clinic sessions 
every three to six months based on the "mini-clinic" model used in Britain. 
These sessions included individual visits with each member of a multi-
disciplinary team and a group education/peer support meeting. After 24 
months, the intervention group received more preventive services, 
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experienced improved quality of life (measured by the SF-36 
questionnaire and bed disability days), but showed no significant 
improvement in HgbA 1 c. Intervention subjects had increased primary 
care visits, but needed fewer emergency room and specialty visits. 
One study expressly compared group to individual diabetes 
education using a consistent, evidence-based curriculum modeled on the 
National Standards for Diabetes Self-Management Education (DSME). 
The entire program consisted of four sessions over a six-month period led 
by a nurse and a dietician. The individual and group programs were 
equally effective at improving knowledge, behavior, attitudes and quality of 
life. However, the subjects in the group intervention had a statistically 
significant greater reduction of HgbA 1 c compared to the control group 
(2.5% vs. 1.7%, p=0.05).[33] 
An innovative study from Italy examined the effectiveness of group 
visits with structured education for routine diabetes care as an alternative 
to individual visits with support education. After two years of follow-up, 
patients in the group visits had stable HgbA 1 c levels compared to 
elevated levels in the control group (p<0.002).[34] 
As with the majority of diabetes education research, there is great 
diversity in the group programs studied. Group sizes ranged from 4 to 20 
patients. Group leaders varied from a single provider to a multi-
disciplinary team. Professionals involved included physicians, registered 
nurses, dieticians, psychologists, certified diabetes educators, social 
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workers, podiatrists, and pharmacists. Programs have been studied in the 
United States and internationally; in private clinics, academic centers, and 
large HMO's; and in both diabetes specialty clinics and primary care 
clinics. Also significant is the wide range of organization and content for 
the group visits themselves; some were strictly education programs, while 
others included a disease management component. Frequency, duration, 
and session time varied greatly. Despite these differences, many 
similarities in program design exist. Most applied the theories of active 
adult learning and social support. Curricular content, when described, 
followed very similar basic themes as recommended by the National 
Standards for DSME. Overall, this diverse research presents some 
promising evidence for the potential role of group visits in diabetes 
education and disease management. 
CHARACTERISTICS OF THE INTERVENTION-PROGRAM DESIGN 
Our program was designed based on the knowledge of previous 
programs found in the literature and based on several key theories of 
behavior change and adult learning. 
1) Transtheorectical model: The stages of change theory was 
incorporated explicitly into the curriculum-both for developing 
individualized goals for patients but also as a teaching tool to help patients 
understand their own patterns of behavior change. We included an 
explicit explanation of the stages of change within the curriculum and 
11 
asked patients to assess their own stages for particular behaviors related 
to diabetes during group discussions. 
2) Social Support: Our goal was to encourage group interaction and 
support between the group members. Enabling and encouraging group 
participation and sharing of individual experiences with diabetes helps to 
create supportive relationships apart from the doctor-patient relationship. 
Further, we hoped that the group members might find more cultural and 
lifestyle similarities with each other that would promote learning and 
motivation not always possible with professionals. 
3) Active adult learning: Participants were encouraged to participate, ask 
questions, and help shape the content of discussions. The overall course 
design minimized the amount of time spent on didactic teaching and 
focused more on question and answer sessions as well as hands-on 
activities and group discussion. Homework was incorporated into the 
design to keep participants actively involved during the time between 
sessions. 
The group visits were led by one of two primary care providers with 
special interest in diabetes, one FNP/CDE and one Family Physician. 
Nursing students or resident physicians observed some of the sessions. 
Clinic staff (nurses or nursing assistants) provided assistance at the 
beginning of each session for vital signs. The choice of a program run 
primarily by a single provider was explicit in order to assess the feasibility 
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of such a program in a smaller primary care setting where access to a 
multi-disciplinary staff is less likely to be available. 
Overall, the program consisted of four 2.5-3 hour sessions every 
two weeks for a total of an eight-week program. Following the eight-week 
program, patients were referred back to their primary care provider for 
ongoing management of their diabetes. Groups were held in an education 
room within the UNC Family Practice Center. Sessions were offered both 
during daytime and evening hours, and spouses or significant others were 
encouraged to attend. 
Each session followed a similar outline. Before the session, the 
provider would review the chart for lab results or ongoing medical issues 
to prepare an individualized plan for each patient-arrangements for 
medication changes, lab tests, or screening exams were made. Vital 
signs including blood pressure and weight using a bio-impedance scale 
were measured. Each session started with an introduction including 
questions from the previous session and goals for the day, followed by an 
interactive teaching session on the main topic for the day, which often 
involved review of homework assigned at the previous session. Group 
members were encouraged to ask questions and participate in discussion. 
A short break including a healthy snack allowed some time for brief (three 
to five minutes) individual assessment time to review individual needs or 
changes. This was followed by a group activity focusing on a hands-on 
skill such as blood glucose monitoring, foot care, or portion sizes. A final 
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wrap-up reviewed questions and presented goals and homework 
assignment for the next session. 
Sessions were billed as routine office visits and coded as an 
established patient, complex office visit (99214) for the first session and 
an established patient, detailed office visit (99213) for the subsequent 
sessions. Visits included a component of history, some physical exam 
and lab assessment, medical decision-making, and extensive counseling 
justifying these codes. 
The curriculum was based on the American Diabetes Association 
guidelines for DSME core content areas.[35] These ten content areas 
ensure that the basic knowledge and behavioral skills are covered. They 
include: 
• Describing the diabetes disease process and treatment options 
• Incorporating appropriate nutritional management 
• Incorporating physical activity into lifestyle 
• Utilizing medications (if applicable) for therapeutic effectiveness 
• Monitoring blood glucose, urine ketones (when appropriate), 
and using the results to improve control 
• Preventing, detecting, and treating acute complications 
• Preventing (through risk reduction behavior), detecting and 
treating chronic complications 
• Goal setting to promote health and problem solving for daily 
living 
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• Integrating psychosocial adjustment to daily life 
• Promoting preconception care, management during pregnancy, 
and gestational diabetes management (if applicable). 
Our curriculum was designed only for patients with Type II diabetes 
so issues related to Type I diabetes such as urine ketones and 
ketoacidosis were not discussed unless questions were raised. Also, 
given to the age of our population, we did not include standard discussion 
of pregnancy-related concerns. The content areas were divided among 
the four sessions beginning with basic knowledge and skills and ending 
with psychosocial aspects of self-care in the last session. 
Session 1 : Introduction to Diabetes 
Topics covered included the definition of diabetes, signs and symptoms, 
and basic treatment methods. Physiology of insulin resistance and basic 
nutrition information was reviewed. Patients participated in a hands-on 
activity to learn self-monitoring of blood glucose. Homework included lab 
tests when appropriate, a three-day food diary, and patients were asked to 
bring two food labels for discussion to the following session. 
Session 2: Living a Healthy Life 
The diabetes food pyramid and meal planning were presented using 
examples from patients own food diaries. Basic educational material from 
the ADA was distrubuted. Some healthy cooking techniques were 
discussed and examples of resources for healthy recipes provided. 
Special emphasis was placed on portion sizes using both plastic models 
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and real food demonstrations. In a hands-on group activity, we practiced 
label reading and made comparisons of different food choices. Key 
concepts such as serving size, importance of all carbohydrate not just 
sugar, and goals for total fat and saturated fat intake were stressed. 
Exercise and its relationship to blood sugar control was discussed, and 
homework included a three-day activity diary and pre- and post-exercise 
blood glucose testing. 
Session 3: Living in the Doctor's World: Goals for Treatment 
Exercise diaries were reviewed as well as blood glucose responses to 
exercise followed by a presentation of the basic categories of medication 
with links to the pathophysiology of disease. The group was then asked to 
develop a list of complications caused by diabetes using a drawing of the 
human body as a visual tool. Once a complete list was generated, 
fundamental prevention measures such as blood pressure control, eye 
exams, and cholesterol lowering were reviewed. Patients were given an 
individualized diabetes report card to follow their required preventive 
services and to set personal goals for treatment. The hands-on skill 
session reviewed basic do's and don'ts of foot care and individual foot 
exams. Homework was assigned to think about the issues related to 
behavior change. The stages of change model was introduced. Patients 
were asked to think of one success and one failure that they have had in 
dealing with diabetes. 
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Session 4: Putting It All Together: The Key to Happiness and Health 
This session emphasized the challenges of making lifestyle changes. 
Discussion of the homework assignment prompted patients to develop a 
list of helpful and harmful techniques to maintain successful change. 
Using the stages of change model as a framework, we discussed taking 
small steps towards success. We discussed the effect of illness on 
diabetes and reviewed the basic steps to managing sick days as well as 
danger signs. We then discussed the role of emotional stress and its 
effect on diabetes and presented some stress management skills. Finally, 
we addressed the issues of communication with health care personnel 
and with family and friends. Using case examples, we prompted 
discussion of several "what if' scenarios such as how to handle the family 
holiday meal. This final session ended with a diploma ceremony for each 
participant. 
METHODS: CHARACTERISTICS OF THE EVALUATION 
Study Design 
This study was a feasibility study designed as a non-randomized, 
pre- and post-intervention evaluation. The research question was whether 
a provider-run, diabetes group visit program was feasible in our academic 
family practice center. Future research will require an experimental 
design with control subjects to determine true effectiveness. 
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Setting 
The setting was the University of North Carolina Family Practice 
Center in Chapel Hill, North Carolina, a large primary care clinic with 
45,000 patient visits per year with both resident and faculty providers. 
Patients have diverse backgrounds, including highly educated university 
personnel, rural farmers, and elderly Medicare patients. 
Recruitment of Subjects 
Subjects were recruited from continuity patients at the UNC Family 
Practice Center identified as having Type II Diabetes by ICD-9 diagnosis 
codes. Letters were sent to over 740 patients with diabetes announcing 
the new program and asking interested patients to call the study 
coordinator or to speak with their physician. Fliers were sent to each of 
the physicians in the practice; announcements were made at clinic 
meetings to make providers and staff aware of the program; and 
informational posters were placed in each exam room. Patients could be 
referred to the program either by their physician or at their own request. 
Once a patient was referred to the program, the research assistant 
contacted patients by telephone to explain the program, review the study 
components, and obtain a basic verbal consent for the program. A 
telephone script was used for these phone calls. Basic exclusion criteria 
were reviewed with each patient. These included patients under age 18, 
pregnancy or planned pregnancy within the next year, inability to 
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participate in all four session, and plans to change providers within the 
next 12 months. 
Specific cost information was explained to each potential participant 
including relevant co-payments and other charges. The overall charge for 
the program was $319 plus the cost of any indicated lab tests. All of the 
testing done for the study and the visits themselves were felt to be 
consistent with routine diabetic care and, therefore, patients and their 
insurance were billed. 
Following the telephone interview, patients either declined to enroll 
in the program or were scheduled for the next group session. Figure 1 
displays the number of patients initially recruited, the number enrolled, and 
the number who attended. Primary reasons for declining the program 
included schedule conflicts, cost and lack of insurance, and new health-
related concerns with higher priority. The patients identified by this type of 
recruitment are self-selected or physician-selected and are likely to be 
more motivated than the average diabetic population. 
Written informed consent was obtained at the beginning of the first 
session. The Institutional Review Board for the UNC School of Medicine 
approved our study. 
Data and Data Collection 
Baseline demographic and clinical information was obtained for all 
patients who enrolled in the group visit program using review of the 
electronic medical record. Specific clinical data such as duration of 
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diabetes, medications, co-morbid conditions, presence of complications, 
and previous lab test results were recorded. Lab data were considered 
baseline if tests had been done within the standard recommendations for 
routine diabetes care. For example, HgbA1c results were considered 
baseline if drawn less than three months before the onset of the first group 
session whereas cholesterol and urinary microalbumin results were 
baseline if done within the last 12 months. If subjects did not have 
documentation of baseline lab results, arrangements were made to have 
them done within the first two weeks of the group visit program. 
Outcome measures were divided into five basic categories: 1) 
Clinical measures; 2) Attitudes and self-efficacy measures; 3) Quality of 
life measures; 4) Quality of care; and 5) Utilization measures. 
Clinical Outcomes 
HgbA 1 c was measured using the DCA 2000 Analyzer by Bayer 
Diagnostics, with a normal range 4.8-6.0%. These values were obtained 
from electronic chart review at the onset of the group program and at six 
months after the intervention when possible. Long-term follow-up will also 
include 12-month measures. Subjects were to obtain these tests as part 
of the routine management of their diabetes. However, due to low 
compliance with these routine recommendation discovered during the 
process of this research, reminder messages were sent to patients and 
their primary care providers to ensure this and other clinical testing was 
done. 
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Total cholesterol (and, when possible, calculated LDL cholesterol) 
was followed at baseline and 12 months. These were measured using 
materials provided by Roche Diagnostics. The normal range for total 
cholesterol is 1-199 mg/dl and 1-129 mg/dl for LDL. 
Weight and Body Mass Index were measured using a bio-
impedance scale at each of the group sessions. Follow-up weight was 
recorded from electronic chart review from subsequent patient visits at six-
month and 12-month endpoints. Visits within four weeks of the time point 
(before or after) were considered adequate for each follow-up measure. 
These were typically obtained with a basic balance scale and BMI was 
calculated using known height. 
Systolic and Diastolic Blood Pressures were obtained at the onset 
of each group sessions by clinical support staff using the traditional 
auscultation technique. Follow-up blood pressure measures documented 
at routine clinic visits at six-month and 12-month points were obtained 
from electronic chart review. Visits within four weeks of the time point 
(before or after) were considered adequate for each follow-up measure. 
Attitude and Self-Efficacy 
Attitudes and self-efficacy were measured using a previously 
designed and validated survey called the Diabetes Empowerment Scale, 
developed by Anderson et al at the University of Michigan.[36] Permission 
was obtained from the University of Michigan Diabetes Research and 
Training Center for use of this instrument. It is a 28-item Likert-type 
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questionnaire that addresses attitudes about diabetes on a 1 to 5 scale. 
An overall score is measured as well as three subscales: Managing the 
Psychosocial Aspects of Diabetes, Assessing Dissatisfaction and 
Readiness to Change, and Setting and Achieving Diabetes Goals. A 
higher score indicates better attitudes about diabetes and increased self-
efficacy. 
Subjects completed questionnaires at the onset of the program, on 
completion of the four session, at six-months, and at 12-months. Both six-
month and 12-month questionnaires were mailed to subjects' homes with 
return envelopes and postage provided along with a reminder phone call. 
Quality of Life 
The SF-12® survey, a shortened version of the SF-36® survey that 
has been validated in many disease processes, was used to assess 
health-related quality of life.[37, 38] This survey has subscales for both 
physical (PCS) and mental (MCS) health components. Permission was 
obtained for use from Quality Metric Incorporated. An online scoring 
service was used to analyze the data using the weighted analysis 
designed and tested for this survey. As a reference, the mean score 
found in a general U.S. population was 50.12 (SD 9.45) for the PCS and 
50.04 (SD 9.59) for the MCS. Higher scores indicate better quality of 
life.[39) 
Subjects completed the SF -12® surveys at onset of the group 
sessions, at the end of the last session, and at 6-month and 12-month 
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follow-up points. Surveys were mailed along with the Empowerment 
questionnaires. 
Future Outcome Measures 
Both quality of care and health care utilization are important long-
term measures of any clinical diabetes program. These measures will be 
examined after 12 months of follow-up to look for any effect of enrollment 
in the program. 
Quality of care measures will include use of recommended 
medication such as aspirin and ace-inhibitors and rates of annual eye 
exams and influenza immunizations. These measures will be examined at 
baseline through medical chart review and direct history from the patient. 
Final comparison of these measures will be looked at after 12 months to 
see if rates change over a 12-month period. 
Healthcare utilization will be tracked using an administrative 
database for the entire university health care system. Office visits, 
emergency room visits, and hospitalizations within the UNC system in the 
12 months prior to the program will be compared to the 12 months after 
the intervention. 
Analysis 
Descriptive statistics were obtained to determine the baseline 
characteristics of the enrolled subjects for important demographic and 
clinical areas. Pre-intervention and post-intervention outcomes measure 
means were calculated and compared. Values are presented as means 
23 
or percentages where appropriate. This study's primary goal was to 
assess the feasibility of this group visit program in our setting. Therefore, it 
was not designed to have adequate power to detect differences in any of 
the outcomes areas. Measures of statistical significance would be 
misleading and are not reported. 
IMPLEMENTATION OF THE PROJECT 
The most challenging aspect of implementation was contacting and 
scheduling patients. A part-time research assistant working 8-10 hours 
per week spent much of her time making repeated phone calls in order to 
reach patients on the telephone. Even though they made inquiries about 
the program, we were not able to contact 30% of interested patients, 
primarily due to lack of access to work phone numbers and incorrect 
phone numbers. Of those patients who agreed to enroll in the program, a 
significant number of patients did not show up for any of the classes (15 
out of 47). One entire group had to be re-scheduled to start the following 
week as only one of the six subjects showed up for the first session. More 
frequent phone call reminders, contacts made during evening hours, and a 
better system of mailing notices to patients may have helped attendance 
rates. Involvement of the primary care provider in this contact process 
may help to encourage better enrollment and attendance rates. 
Incorporating a new clinical program into an already busy clinic 
system was another challenge. All plans were reviewed with clinic 
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managers, nursing, and lab personnel to anticipate any potential 
problems. We had to carefully choose the times and days of the week for 
the session so that the arrival time of the group patients would not 
overwhelm clinic staff. Informing and working with front desk staff in the 
clinic made processing referrals, answering patient questions, and overall 
scheduling of patients somewhat easier. 
Overall attendance was fair. Two subjects attended only the first 
session while 11 out of 32 subjects attended all four session. On average, 
subjects attended three sessions. Reasons for missing a session included 
transportation problems, family or personal illness, or failing to remember. 
Subjects were not called between sessions, but they did receive a 
computerized reminder card before each meeting. 
The lower rates of enrollment and attendance than anticipated 
weakened the cost-effectiveness of the program. Overall, the six cohorts 
required 24 half-day sessions of provider time. The total amount billed for 
the entire program was $8983, approximately $375 per session. This is 
about half of what each provider would typically bill in a continuity clinic 
half-day session. Some of this reduced billing can be justified by the 
limited use of clinic resources such as nursing needs and clinic rooms, but 
to be cost-neutral for our clinic, group size needs to reach eight or nine 
patients. 
Provider time involved in the sessions improved with experience. 
Chart review forms were created to make history gathering easier before 
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the first session and to facilitate data entry. Time for each patient's chart 
review ranged from five to ten minutes. A progress note for each session 
was dictated using pre-designed forms to generate uniform and rapid 
documentation. Overall, providers spent approximately 20-30 minutes 
prior to each session in preparation and about 30 minutes following the 
session for documentation. Preparation of folders for each patient with 
packets for each session's educational materials and homework helped 
limit the amount of provider time required before the meeting. 
Running the sessions efficiently was also a skill that improved with 
time. The first and last sessions were the most difficult because a 
significant amount of time was spent reading the consent form and 
completing the two questionnaires. Keeping to a clearly outlined 
scheduled helped ensure that all topics for the day were covered. Overall, 
there was less time than anticipated for the individual assessments during 
the break, but many patients used group time to discuss their individual 
concerns. Some management decisions such as medication changes 
were made at the end of the session as other members were leaving. 
Supplies that were developed over the first few runs of the program 
included posters for the education room that highlighted key points of the 
curriculum such as the four key pillars of diabetes treatment; HgbA1c, 
LDL, and blood pressure goals; and the stages of change model. A large 
dry-erase board was essential to facilitate group discussion and record 
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group agenda or questions. A snack and beverage was supplied at each 
session due to the nearly three-hour duration. 
RESULTS OF THE INITIAL PILOT STUDY 
Baseline demographic characteristics of the subjects enrolled in the 
group visit program are shown in Table 3. The mean age of participants 
was 54 years. Participants were more likely to be African-American than 
white (75%) and more likely to be married than not (61 %). Very few 
subjects were without insurance (2 out of 32). Level of education was 
fairly high with over 60% of the subjects having attended some college. 
Three subjects ( 11 %) did not complete high school. The majority had 
never attended a diabetes education program before. 
Clinical characteristics at baseline are shown in Table 4. Overall, 
the mean HgbA 1 c was 8.05% (SD 1.8) slightly higher than the average for 
our overall clinic population, which is 7.9% (SD 1.3). Average Body Mass 
Index (BMI) was 33.2 kg/m2. Three-quarters of the subjects used some 
type of medication for management of their diabetes, and nearly half had 
evidence of at least one micro-vascular complication of diabetes 
(neuropathy, retinopathy, or nephropathy). Based on chart review of 
primary care visits and hospitalization reports, 72% of the subjects had 
hypertension, 63% had hypercholesterolemia, and 19% had known 
coronary artery disease. 
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Of the 32 subjects who attended at least one session, only the 24 
subjects who attended three of the four sessions were included in the 
comparison of the pre- and post-intervention outcomes. Several subjects 
had incomplete data, missing either clinical measures such as blood 
pressure and weight due to late arrival at the session or incomplete 
surveys. Of the 12 subjects enrolled in the first cohort, only seven 
returned completed six-month survey results. Eight had six-month 
HgbA 1 c values drawn, and 10 had blood pressure values documented in 
the clinic record at six months. 
Results of the pilot study are shown in Table 5. HgbA1c, weight, 
BMI, and blood pressure all showed small improvements. Attitudes about 
diabetes and self-efficacy (as measured by the Diabetes Empowerment 
Survey overall score) demonstrated improvement at 8-weeks, but a return 
to baseline levels at 6-months. This finding was evident in all three of the 
subscales as well. Quality of life (as measured by the SF-12® survey) 
showed minimal improvement after the intervention. 
DISCUSSION 
This study demonstrated the feasibility of provider-run group visit 
program for diabetes education and management in a university-based, 
primary care clinic. Overall, there were trends towards improved outcomes 
in clinical areas such as HgbA1c, BMI, and blood pressure control. As 
found with other short-term interventions, our program improved attitudes 
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about diabetes, self-efficacy, and quality of life after the eight-week 
intervention, but it did not show lasting benefits in these areas at six 
months. 
This feasibility study identified important problem areas when 
implementing this type of program in a real-world clinic setting. We 
attempted to create and implement this program with limited resources 
and support staff; somewhat similar to what most primary care clinics 
would be able to dedicate to such a program. Because of these limited 
resources, implementation was challenging with the most difficult area 
being patient recruitment and enrollment. We found that of the 84 
inquiries made about the program, only 32 (38%) patients actually 
attended a session. This represents less than 15% of our clinic's total 
diabetic population. Maintaining attendance was also difficult with only 
one-third of subjects attending all four sessions. This low level of interest 
in diabetes education and management is not surprising. One survey in 
Philadelphia found that only 22% of subjects with diabetes had ever 
attended a diabetes education program and found that physician 
recommendation, female gender, insulin use and higher degree of obesity 
were important predictors of attendance.[40] Future strategies must 
develop ways to increase the interest in diabetes education programs and 
in reducing barriers to attendance. Our program will need to increase 
exposure of patients to the idea of the diabetes program and to strengthen 
the primary care physician's role in recommending the program. Greater 
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incentives and systems to promote attendance may be helpful. Increased 
group size and more consistent attendance will improve the cost-benefit 
ratio for the clinic as a whole-making the clinician time devoted to the 
group sessions worthwhile. 
Another challenging aspect of implementation was designing and 
running the group sessions themselves. We struggled to design each 
session with the right balance of information, hands-on skills, and group 
discussion. It was always a challenge to keep each group session well 
organized and with efficient flow so that all the educational topics were 
covered and so that individuals could participate freely in group 
discussion. With time, this skill improved for both group leaders. Future 
research should identify which aspects of the curriculum are the most 
effective. Qualitative feedback from group participants may contribute 
useful information as well. 
This pilot study has several limitations. The subjects were not 
randomized, and there was no control population. As this was a 
feasibility study, we needed to recruit enough patients in order to run 
several group sessions. The patients were likely to be a highly motivated 
group as they were either self-selected or identified by their primary care 
physician. Involvement was voluntary, and analysis included only those 
subjects who agreed to participate. The effects of this program cannot be 
generalized to all patients with diabetes. To truly evaluate the 
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effectiveness of this intervention, a randomized controlled trial will be 
needed to eliminate the bias of selection and other confounding factors. 
Because this study was conducted in a real-world clinical setting, 
most of the data collection was obtained from routine clinical care, and not 
research-driven protocols. This fact limited the completeness and 
precision of the values collected. For example, clinical data such as blood 
pressure levels were obtained from chart review of routine primary care 
visits. No attempt was made to standardize the way that our clinic staff 
measured blood pressure. Similarly, HgbA1c at six-month follow-up was 
identified through chart review. Only a disappointing two-thirds of patients 
had a follow-up value measured between five and seven months after 
involvement in the program. 
Another potential limitation is the variation between the two 
providers leading the group sessions. Differences in experience, teaching 
style, and personality may have had dissimilar effects on patients. The 
curriculum outline and materials used were standardized to limit this 
variation as much as possible. 
The greatest limitation of this intervention is its short duration. 
Patients did demonstrate changes in attitude and self-efficacy on 
completion of the eight-week intervention; but it is maintaining these 
improvements over time that may have the greatest health impact. Group 
visit interventions with longer duration (at least six months) have often 
demonstrated more improvement in glycemic control.[29, 31, 33] 
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A short-term group visit program in a primary care clinic appears 
feasible, though patient recruitment and attendance need to be improved 
to maximize cost-effectiveness. Developing an even more innovative 
model of care is the next step, involving group visits for routine diabetes 
management and education instead of individual, primary care visits. This 
has been done in a few selected settings, most notably two large HMO 
studies and in a specialty-run diabetes clinic in ltaly.[31, 32, 34) 
Determining whether primary care providers in a non-specialty based 
clinic can apply this model; whether it will be efficient and cost-effective; 
and whether it will improve health outcomes needs to be studied. 
Providing more efficient and effective primary care strategies for the 
growing diabetic population is an essential undertaking for our healthcare 
system. A group visit program for management of diabetes in primary care 
may meet this challenge. 
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Table 1-Curative Factors of Group Therapy[12] 
Curative Factor Clinical Examples 
Interpersonal Learning Patients learn from each others experiences 
with diabetes 
Catharsis Sharing the emotions associated with diabetes 
such as venting anger and sharing fears 
Group Cohesiveness Sense of belonging to the group helps to 
promote self-esteem and decrease isolation 
Insight Listening to others with diabetes can help 
patients to understand why they feel or act the 
way that they do. 
Development of Getting feedback from others helps to motivate 
Socializing Technique change 
Existential Factors Membership in the group may help to generate 
improved outlook on fife 
Universality Realizing that they are not alone and that other 
people struggle with the same problems with 
diabetes 
Instillation of hope Learning from others who have been more 
successful with their diabetes 
Altruism Feeling that the members of the group are 
helping one another can be empowering 
Corrective recapitulation Group may provide a more positive outlook on 
of family of origin family relationships 
Imparting information Sharing of information and learning from each 
others problem-solving attempts 
Imitative behavior Modeling new behaviors after others in the 
group who have been more successful 
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Table 2- Review of Randomized Controlled Trials Using A Group Visit Model for Diabetes 
Frequency of sessions 
Study Design Setting Intervention description Population Group size Duration of Follow-up Outcomes 
Sadur et al.[31] Randomized Large Multiwdisciplinary Poorly controlled 10-18 Monthly for six months HgbA 1c decreased by 1.3% vs. 0.02% 
controlled trial HMO (RN/CDE/Psych/RD) Type II OM (no patients with RN phone follow-up (p<0.0001) 
Diabetes Care team-led group sessions AIC or>8.5) 
1999 us Six month to one year Decreased utilization and increased self-
97 Intervention follow-up efficacy 
88Control 
Wagner et al[32] Randomized Large Multi-disciplinary team Type II OM 6-10 patients Every three to six months No difference in A1c, but did show a trend 
controlled trial HMO with primary care MD, for decreased A1c with increased 
Diabetes Care RN, pharmacist, SW 278 Intervention attendance 
2001 (Randomized by us 479 Control 
clinic site) Seen by MD-then had Increased preventive services, satisfaction 
group education, social 35% invited with OMeara 
support and self- never attended Increased office visits, but decreased ER 
management visits 
Group led by RN/SW 
"Mini-clinic" model as in 
Britain 
Trento et al[34l Randomized General Routine group visit with Type II DM 9-10 patients Every three months A1c remained stable in group vs. 
controlled trial Medicine MD vs. individual (Four sessions per year) worsened in individual visits (p=0.0002) 
Diabetes Care Clinic with consultations 56 Intervention 
2001 diabetes 56 Control Two year follow-up Increased knowledge, Quality of Life, and 
focus 1 hour group sessions behaviors 
run my 1-2 physicians Physicians spent less time, patient had 
Italy and an educationist more MD time 
Patients seen one-on-one 
by MD if individual 
attention needed 
Rickheim et Randomized Minnesota Group vs. Individual Type II DM 4-8 patients Four sequential sessions Overall A1c went from 8.5% to 6.5% after 
al[33] Controlled Trial education sessions with over six months 6 months 
an evidenced based 87 Intervention 
Diabetes Care curriculum 83 Control Total of five to seven A1c decreased by 2.5% vs. 1.7% in group 
2002 hours vs. control subjects (p=0.05) 
Led by RN and RD 
Six month follow-up No difference in knowledge, behaviors, Qu~iitY of life, or attitud~-(both effectiv9) 
Raz et al[27] Randomized Diabetes Group diabetes clinic 51 patients Unknown Three weekly lessons Decreased A1c by 1.5-2% after 12months 
Controlled Trial clinic held every 4 months vs. every four months (p<0.05) 
Diabetes Care individual sessions only Volunteer 
1988 Stratified based every 2 months patients only 12 month follow-up No change in knowledge or weight 
on level of Israel 
control Led by MD/RN/RD/PT 
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Table 2 (continued) 
I 
Monthly group sessions 
Southern I Used waiting list I with emphasis on 28 Intervention 
Medical Journal subjects as behavior change and life 28Control 
I 
112 month follow-up I LDL and cholesterol dropped as well 
1999 contol patients skills at six months in the intervention 
30% drop out Cost $195 group 
involved on rate 
periphery-:--Supportive 
~.rson et Randomized Communi! Group education 64p 
al[28] Controlled Trial y sessions with focus on (46 random, 18 sessions 11.02% in intervention group 
patients empowerment for self not randomly compared to 10.82% to 10.78% in 
Diabetes Care Used waiting list care assigned) 12 week follow-up the control group (p=0.05) 
1995 subjects as University 
control of Presentations, Improved self-efficacy for goal 
Michigan worksheets setting, managing stress, obtaining 
support, and making decisions 
1ily involvement 
ged 
)torial intervention Type ll DM Unknown Three individual sessions Improved A1c from 8. 
trial Center with both intensive group age 45~65 and two large group the intervention group"* compared to 
Diabetic 
I 
education and sessions with 20 a 0.2% increase in the control group 
Medicine Denmark pharmacological therapy 160 patients patients/spouses (p<,0.000001) 
2001 
Stano Run by a diabetes team Smoking cessation group **Likely due to other aspects of 
Type2 with physician, dietician sessions with 14 patients intervention such as medication 
Study and nurse management 
No change in lifestyle measures such 
as exercise or smoking, minimal 
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Figure 1-Recruitment of Subjects 
Recruitment 
Letters to 7 40 patients with DM 
Fliers and announcements to physicians 
Posters in exam rooms 
84 Inquires over 8 months 
15 Patient Requests 
53 Provider Referrals 
Agreed to program but 
never attended 
15 subjects (18% oftotal) 
16 Other or unknown 
Declined Program 
when program 
explained 
12 subjects (14% oftotal) 
2 (17%) Cost 
4 (33%) Time/Schedule 
1 (8%) Health Issues 
4 (33%) Not interested 
Unable to Contact 
25 subjects (30% of total) 
Patients Enrolled and Attended 
Total 32 subjects (38% of total) 
6 groups 
Morning Sessions (17 total) 
Cohort 1A-7 subjects 
Cohort 2A--6 subjects 
Cohort 3A--4 subjects 
Evening Sessions (15 total) 
Cohort 1 8-5 subjects 
Cohort 28--4 subjects 
Cohort 38---6 subjects 
Attendance Rates 
1 session-2 subjects 
2 sessions-6 subjects 
3 sessions-13 subjects 
4 sessions-11 subjects 
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(6%) 
(19%) 
(41%) 
(34%) 
1 
; 
l 
j 
Table 3-Demographics of Study Population 
Characteristic (N=32) Mean (SO) or % (N) Range 
Age 54.2(11.2) 31-75 
Year of Diagnosis 1995 1982-2002 
Marital status 
Manied 61% (19) 
Widowed 3% (1) 
Single 23% (7) 
Divorced 13% (4) 
Unknown 3% (1) 
Race 
Black 75% (24) 
White 25% (8) 
Gender 
Female 50% (16) 
Male 50% (16) 
Insurance type 
Medicaid 3% (1) 
Medicare 16% (5) 
Private 75% (24) 
None 6% (2) 
Education Level 
Some High School 11% (3) 
Completed High School 29% (8) 
Some College 61% (17) 
Ever attended DM education 
Yes 7% (2) 
No 93% (28) 
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Table 4-Baseline Clinical Characteristics 
Characteristic Mean (SD) or % (N) Range 
HbgA1c (n-31) 8.05 (1.8) 4.7-12.8 
Total cholesterol (n-28) 206.9 (44) 132-339 
LDL (n=19) 121.1 (26) 80-171 
HDL (n=28) 48.6(12) 32-79 
Triglycerides(n=19) 159.4(96) 66-511 
Body Mass Index (n-32) 33.2 (7) 19-52.7 
Systolic Blood Pressure (n-31) 143.7 (17.7) 118-180 
Diastolic Blood Pressure (n-31) 83.9 (12.5) 54-110 
DM Management 
Diet only 22% (7) 
Oral medications 66% (21) 
Insulin + oral meds 6% (2) 
Insulin only 6% (2) 
Microvascular Complications 
Yes 47% (15) 
No 41% (13) 
Unknown 12% (4) 
Hypertension 
Yes 72% (23) 
No 25% (8) 
Unknown 3% (1) 
Coronary Artery Disease 
Yes 19%(6) 
No 47%(15) 
Unknown 34%(11) 
Hypercholesterolemia 
Yes 63%(20) 
No 25%(8) 
Unknown 12%(4) 
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Table 5- Results of the Intervention 
Outcomes Baseline Sweeks* 6 month** 
Clinical Measures N Mean(SO) N Mean (SO) N Mean (SO) 
HgbA1c (%) 31 8.05 (1.8) 8 7.79 (1.4) 
Weight (lbs) 32 223 (49) 24 219 (45) 
BMI (kg/m') 28 33.6 (7.2) 23 32.9 (6.1) 
Systolic BP (mmHg) 28 144.5 (18) 22 141.0 (22) 10 138.5 (20) 
Diastolic BP (mmHg) 32 83.8 (13) 22 80.4 (12) 10 74(13) 
Self-Efficacy/Attitude 
(DES) 
Psychosocial attitudes 29 3.82 (0.60) 22 4.32 (0.51) 7 3.73 (0.42) 
Readiness to change 28 3.80 (0.53) 22 4.31 (0.50) 7 3.94 (0.31) 
Goal-setting 27 3.99 (0.48) 22 4.40 (0.41) 7 3.94 (0.24) 
Overall empowerment 27 3.87 (0.47) 22 4.35 (0.44) 7 3.87 (0.28) 
Quality of Life 
(SF-12®) 
Physical Component 28 41.7 (8.1) 18 42.8 (8.4) 7 41.5 (10.7) 
Score(PCS) 
Mental Component 28 45.3 (10.3) 18 47.6 (8.8) 7 46.5 (8.9) 
Score (MCS) 
*For eight-week clinical follow-up, subjects who attended at least three sessions but 
missed the last session were included with values from the 3'd session (six weeks). 
**HgbA 1 c, SBP, and DBP measures were included from five to seven months after the 
intervention. 
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